Taylor & Francis Group
Browse

Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancer. Supplementary figures

Download all (1.29 MB)
figure
posted on 2023-02-13, 10:20 authored by Tingbo Liang, Xingyuan Xu, Xiaozhen Zhang, Qi Chen, Jian Xu, Enliang Li

Supplementary figures 1 and 2

History

Usage metrics

    Immunotherapy

    Categories

    Keywords

    galectin-9immune checkpointimmune therapypancreatic cancerPD-L1

    Licence

    CC BY-NC-ND 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC